Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy

Perfusion

Volumn 22, Issue 1, 2007, Pages 67-69

  Pappalardo, Federico ^a   Franco, A ^a   Crescenzi, G G ^a   Poli, A ^a   Zangrillo, A ^a   Koster, A ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Deutsches Hertzentrum Berlin ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FRESH FROZEN PLASMA; HEPARIN; HIRULOG; HISTAMINE H1 RECEPTOR ANTAGONIST; METHYLPREDNISOLONE;

AGED; ANAMNESIS; ANESTHESIA INDUCTION; ANTICOAGULATION; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ERYTHEMA; EXTRACORPOREAL CIRCULATION; FEMALE; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; INTENSIVE CARE UNIT; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PRURITUS; SKIN TEST; THROMBOSIS PREVENTION; ULTRAFILTRATION;

CARDIOPULMONARY BYPASS; DRUG HYPERSENSITIVITY; HEPARIN; HIRUDINS; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

EID: 34347379536     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659106076004     Document Type: Article

References (10)

1. Parekh K, Burkhart H, Hatab A et al. Heparin allergy: successful desensitization for cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130: 1455-56.
2. Bottio T, Pittarello G, Bonato R et al. Life-threatening anaphylactic shock caused by porcine heparin intravenous infusion during mitral valve repair. J Thorac Cardiovasc Surg 2003; 126: 1194-95.
3. Dyke CM, Smedira NG, Koster A et al. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study. J Thorac Cardiovasc Surg 2006; 131: 533-39.
4. Smedira NG, Dyke CM, Koster A et al. Anticoagulation with bivalirudin for off-pump coronary artery grafting: the results of the EVOLUTION-OFF study. J Thorac Cardiovasc Surg 2006; 131: 686-92.
5. Koster A, Spiess B, Chew DP et al. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 2004; 93(3): 356-59.
6. Koster A, Yeter R, Buz S et al. Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study. J Thorac Cardiovasc Surg 2005; 129(6):1391-94.
7. Jappe U, Gollnick H. Allergy to heparin, heparinoids, and recombinant hirudin. Diagnostic and therapeutic alternatives. Hautarzt 1999; 50: 406-11.
8. Greinacher A, Lubenow N, Eichler P. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. Circulation 2003; 108: 2062-65.
9. Zucker ML, Koster A, Prats J, Laduca FM. Sensitivity of a modified ACT test to levels of bivalirudin used during cardiopulmonary bypass. J Extra Corp Technol 2005; 37(4): 364-68.
10. Veale JJ, McCarthy HM, Palmer G et al. Use of bivalirudin as an anticoagulant during cardiopulmonary bypass. J Extra Corp Technol 2005; 37(3): 296-302.